Short Description Leipzig professor & Rejuvenate Bio CSO advancing gene therapies for aging.
Description Dr. Alexandra Stolzing’s research spans stem‑cell senescence, autophagy induction, and CRISPR‑based rejuvenation. As Chief Scientific Officer at Rejuvenate Bio she oversees multiplexed gene‑therapy programs targeting FGF21, TGF‑β, and αKlotho. Her academic lab at Leipzig University identified small molecules that restore lysosomal function in aged mesenchymal stem cells, paving the way for enhanced tissue repair. Stolzing mentors women in biotech through the Helmholtz Association and speaks at Reprogramming Science conferences across Europe.